20-O-β-d-glucopyranosyl-20(S)-protopanaxadiol-fortified ginseng extract attenuates the development of atopic dermatitis-like symptoms in NC/Nga mice

Journal of Ethnopharmacology

Volumn 151, Issue 1, 2014, Pages 365-371

  Kim, Jong Rhan ^a,c   Choi, Jinhwan ^a   Kim, Jiyoung ^a,b,c   Kim, Heejeung ^a   Kang, Heerim ^a   Kim, Eun Hye ^a   Chang, Jeong Hwa ^d   Kim, Yeong Eun ^d   Choi, Young Jin ^a,b   Lee, Ki Won ^a,b,c,e   Lee, Hyong Joo ^a,b,c  

^a Seoul National University   (South Korea)

^b Seoul National University   (South Korea)

^c Seoul National University   (South Korea)

^d CJ Corporation   (South Korea)

^e Seoul National University   (South Korea)

Author keywords

20 O d Glucopyranosyl 20(S) protopanaxadiol (GPD; Atopic dermatitis; Compound K); Cytokines; Dermatophagoides farinae; Ginseng

Indexed keywords

20 O BETA DEXTRO GLUCOPYRANOSYL 20 PROTOPANAXADIOL; CD3 ANTIBODY; GAMMA INTERFERON; GINSENG EXTRACT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MACROPHAGE DERIVED CHEMOKINE; MONOCLONAL ANTIBODY CD28; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOPIC DERMATITIS; AUDITORY SYSTEM PARAMETERS; CELL INFILTRATION; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMATOPHAGOIDES FARINAE; DISEASE SEVERITY; EAR THICKNESS; EOSINOPHIL; FEMALE; GINSENG; HISTOLOGY; MAST CELL; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SCRATCHING; SKIN DEFECT; SPLEEN CELL;

DERMATOPHAGOIDES FARINAE; MUS; PANAX GINSENG;

20-O-Β-D-GLUCOPYRANOSYL-20(S)-PROTOPANAXADIOL (GPD; ATOPIC DERMATITIS; COMPOUND K); CYTOKINES; DERMATOPHAGOIDES FARINAE; GINSENG;

ADMINISTRATION, ORAL; ANIMALS; ANTI-ALLERGIC AGENTS; ANTIGENS, DERMATOPHAGOIDES; CYTOKINES; DERMATITIS, ATOPIC; FEMALE; GINSENOSIDES; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, INBRED STRAINS; PANAX; PLANT EXTRACTS; SKIN; SPLEEN; TACROLIMUS;

EID: 84891486307     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2013.10.058     Document Type: Article

References (38)

1. T. Akao, M. Kanaoka, and K. Kobashi Appearance of compound K, a major metabolite of ginsenoside Rb1 by intestinal bacteria, in rat plasma after oral administration-measurement of compound K by enzyme immunoassay Biol. Pharm. Bull. 21 1998 245 249
2. T. Akao, H. Kida, M. Kanaoka, M. Hattori, and K. Kobashi Drug metabolism: intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of Ginsenoside Rb1 from Panax ginseng J. Pharm. Pharmacol. 50 1998 1155 1160
3. K.C. Barnes An update on the genetics of atopic dermatitis: scratching the surface in 2009 J. Allergy Clin. Immunol. 125 2010 16 29
4. K. Breuer, T. Werfel, and A. Kapp Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis Am. J. Clin. Dermatol. 6 2005 65 77
5. L. Chen, O. Martinez, L. Overbergh, C. Mathieu, B.S. Prabhakar, and L.S. Chan Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model Clin. Exp. Immunol. 138 2004 375 387
6. E. Cho, and S.H. Cho Effects of Korean red ginseng extract on the prevention of atopic dermatitis and its mechanism on early lesions in a murine model J. Ethnopharmacol. 145 2013 294 302
7. J.H. Choi, S.W. Jin, B.H. Park, H.G. Kim, T. Khanal, H.J. Han, Y.P. Hwang, J.M. Choi, Y.C. Chung, S.K. Hwang, T.C. Jeong, and H.G. Jeong Cultivated ginseng inhibits 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice and TNF-alpha/IFN-gamma-induced TARC activation in HaCaT cells Food Chem. Toxicol. 56 2013 195 203
8. M.K. Choo, E.K. Park, M.J. Han, and D.H. Kim Antiallergic activity of ginseng and its ginsenosides Planta Medica 69 2003 518 522
9. L.A. Dent, M. Strath, A.L. Mellor, and C.J. Sanderson Eosinophilia in transgenic mice expressing interleukin 5 J. Exp. Med. 172 1990 1425 1431
10. S.R. Durham, S. Ying, V.A. Varney, M.R. Jacobson, R.M. Sudderick, I.S. Mackay, A.B. Kay, and Q.A. Hamid Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia J. Immunol. 148 1992 2390 2394
11. P.S. Foster, S.P. Hogan, A.J. Ramsay, K.I. Matthaei, and I.G. Young Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model J. Exp. Med. 183 1996 195 201
12. M. Grewe, C.A. Bruijnzeel-Koomen, E. Schopf, T. Thepen, A.G. Langeveld-Wildschut, T. Ruzicka, and J. Krutmann A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis Immunol. Today 19 1998 359 361
13. B. Homey, M. Steinhoff, T. Ruzicka, and D. Leung Cytokines and chemokines orchestrate atopic skin inflammation J. Allergy Clin. Immunol. 118 2006 178
14. T. Hultsch, A. Kapp, and J. Spergel Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis Dermatology 211 2005 174 187
15. G. Imokawa, A. Abe, K. Jin, Y. Higaki, M. Kawashima, and A. Hidano Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J. Invest. Dermatol. 96 1991 523 526
16. T. Kakinuma, K. Nakamura, M. Wakugawa, H. Mitsui, Y. Tada, H. Saeki, H. Torii, M. Komine, A. Asahina, and K. Tamaki Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis Clin. Exp. Immunol. 127 2002 270 273
17. E.H. Kim, S. Lim, S.O. Kim, S.H. Ahn, and Y.J. Choi Optimization of enzymatic treatment for compound k production from white ginseng extract by response surface methodology Biosci. Biotechnol. Biochem. 77 2013 1138 1140
18. G.R. Lee, and R.A. Flavell Transgenic mice which overproduce Th2 cytokines develop spontaneous atopic dermatitis and asthma Int. Immunol. 16 2004 1155 1160
19. D.Y. Leung, and T. Bieber Atopic dermatitis Lancet 361 2003 151 160
20. D.Y. Leung, R.L. Hirsch, L. Schneider, C. Moody, R. Takaoka, S.H. Li, L.A. Meyerson, S.G. Mariam, G. Goldstein, and J.M. Hanifin Thymopentin therapy reduces the clinical severity of atopic dermatitis J. Allergy Clin. Immunol. 85 1990 927 933
21. D.Y.M. Leung, and T. Bieber Atopic dermatitis Lancet 361 2003 151 160
22. D.Y.M. Leung, M. Boguniewicz, M.D. Howell, I. Nomura, and Q.A. Hamid New insights into atopic dermatitis J. Clin. Invest. 113 2004 651 657
23. R. Nishinakamura, A. Miyajima, P.J. Mee, V. Tybulewicz, and R. Murray Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 functions Blood 88 1996 2458 2464
24. Y. Niwa, T. Terashima, and H. Sumi Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin Br. J. Dermatol. 149 2003 960 967
25. P.Y. Ong, and D.Y. Leung Immune dysregulation in atopic dermatitis Curr. Allergy Asthma Rep. 6 2006 384 389
26. E.K. Park, M.K. Choo, E.J. Kim, M.J. Han, and D.H. Kim Antiallergic activity of ginsenoside Rh2 Biol. Pharm. Bull. 26 2003 1581 1584
27. C. Paul, M. Cork, A.B. Rossi, K.A. Papp, N. Barbier, and Y. de Prost Safety and tolerability of 1% pimecrolimus cream among infants: experience with 1133 patients treated for up to 2 years Pediatrics 117 2006 e118 e128
28. A. Rhule, S. Navarro, J.R. Smith, and D.M. Shepherd Panax notoginseng attenuates LPS-induced pro-inflammatory mediators in RAW264. 7 cells J. Ethnopharmacol. 106 2006 121 128
29. S. Shibata, M. Fujita, H. Itokawa, O. Tanaka, and T. Ishii Studies on the constituents of Japanese and Chinese crude drugs. XI. Panaxadiol, a sapogenin of ginseng roots Chem. Pharm. Bull. 11 1963 759
30. Y.W. Shin, and D.H. Kim Antipruritic effect of ginsenoside rb1 and compound k in scratching behavior mouse models J. Pharmacol. Sci. 99 2005 83 88
31. D. Simon, L.R. Braathen, and H.U. Simon Eosinophils and atopic dermatitis Allergy 59 2004 561 570
32. J.M. Spergel, E. Mizoguchi, H. Oettgen, A.K. Bhan, and R.S. Geha Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis J. Clin. Invest. 103 1999 1103
33. J.M. Spergel, and A.S. Paller Atopic dermatitis and the atopic march J. Allergy Clin. Immunol. 112 2003 S118 S127
34. A. Szegedi, S. Barath, G. Nagy, P. Szodoray, M. Gal, S. Sipka, E. Bagdi, A.H. Banham, and L. Krenacs Regulatory T cells in atopic dermatitis: epidermal dendritic cell clusters may contribute to their local expansion Br. J. Dermatol. 160 2009 984 993
35. C. Wakabayashi, H. Hasegawa, J. Murata, and I. Saiki In vivo antimetastatic action of ginseng protopanaxadiol saponins is based on their intestinal bacterial metabolites after oral administration Oncol. Res. 9 1997 411 417
36. M. Yamaguchi, K. Sayama, K. Yano, C.S. Lantz, N. Noben-Trauth, C. Ra, J.J. Costa, and S.J. Galli IgE enhances Fcε receptor I expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells: synergistic effect of IL-4 and IgE on human mast cell Fcε receptor I expression and mediator release J. Immunol. 162 1999 5455 5465
37. S. Ying, M. Humbert, J. Barkans, C.J. Corrigan, R. Pfister, G. Menz, M. Larche, D.S. Robinson, S.R. Durham, and A.B. Kay Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics J. Immunol. 158 1997 3539 3544
38. J.L. Yu, D.Q. Dou, X.H. Chen, H.Z. Yang, N. Guo, and G.F. Cheng Protopanaxatriol-type ginsenosides differentially modulate type 1 and type 2 cytokines production from murine splenocytes Planta Medica 71 2005 202 207